Applied and Environmental Microbiology, April 2001, p. 1689-1692, Vol. 67, No. 4
0099-2240/01/$04.00+0 DOI: 10.1128/AEM.67.4.1689-1692.2001
Copyright © 2001, American Society for Microbiology. All rights reserved.
Departmento de Nutrición y Bromatología III, Facultad de Veterinaria, Universidad Complutense, 28040 Madrid, Spain,1 and Department of Food Science, Rutgers, The State University of New Jersey, New Brunswick, New Jersey 089012
Received 25 September 2000/Accepted 5 February 2001
| |
ABSTRACT |
|---|
|
|
|---|
Enterocin P is a pediocin-like, broad-spectrum
bacteriocin which displays a strong inhibitory activity
against Listeria monocytogenes. The bacteriocin was
purified from the culture supernatant of Enterococcus faecium P13, and its molecular mechanism of action against the sensitive strain E. faecium T136 was evaluated. Although
enterocin P caused significant reduction of the membrane potential
(
) and the intracellular ATP pool of the indicator organism, the pH gradient (
pH) component of the proton motive force (
p) was not
dissipated. By contrast, enterocin P caused carboxyfluorescein efflux
from E. faecium T136-derived liposomes.
| |
INTRODUCTION |
|---|
|
|
|---|
Bacteriocins produced by bacteria are a heterogeneous group of ribosomally synthesized antimicrobial proteins, which display antimicrobial activity against other bacteria (16, 18, 29). The genus Enterococcus is among the lactic acid bacteria (LAB) associated with foods that produce bacteriocins (2, 4, 6, 11, 12). Enterococcus faecium P13 and other E. faecium strains isolated from dry-fermented sausages produce enterocin P, a bacteriocin with strong inhibitory activity against Listeria monocytogenes (11, 14). Enterocin P is a pediocin-like bacteriocin (27) with an N-terminal signal peptide which may allow it to be secreted via the sec pathway (for a review, see reference 30). The enterocin P operon has been previously characterized (11), and it consists of the bacteriocin structural gene (entP) encoding a 71-amino-acid precursor with a 27-amino-acid signal peptide and has a second open reading frame (orf2) located immediately downstream of entP and potentially encoding the immunity protein.
The increasing interest of consumers in minimally processed, naturally preserved foods has prompted the proposal to use bacteriocinogenic LAB or their bacteriocins as biopreservatives to increase microbiological safety (19, 25, 31). However, rational application of the bacteriocins requires an understanding of the mechanisms underlying their specificity and activity (24, 26), as well as knowledge of the structure-function relationships, to develop new compounds with an improved efficacy. In this context, the objective of this study was to examine the mechanistic action of enterocin P on the sensitive strain E. faecium T136.
| |
MATERIALS AND METHODS |
|---|
|
|
|---|
Bacterial strains and growth conditions. E. faecium P13 (11) and E. faecium T136 (6) were propagated in MRS broth (Difco Laboratories, Detroit, Mich.) at 30°C and used as the enterocin P producer and indicator microorganisms for bacteriocin activity, respectively.
Purification of enterocin P. The bacteriocin was purified from the supernatant of a 16-h E. faecium P13 culture by hydrophobic interaction and cation-exchange chromatographies, basically as described by Casaus et al. (6). Next, the sample was dialyzed against distilled water in dialysis tubing (Spectrum, Houston, Tex.; molecular weight cutoff, 1,000) and concentrated with polyethylene glycol to half of its original volume. This sample was further purified by preparative isoelectric focusing using a Rotofor cell (Bio-Rad Laboratories, Melville, N.Y.), as previously described (8, 10). Fractions displaying the highest antimicrobial activity were pooled together, subjected to ultrafiltration (Centricon-3 concentrators; Amicon; molecular weight cutoff, 3,000), and stored at 4°C until used.
Activity assays.
The antimicrobial activity of the fractions
obtained throughout the purification process was calculated by a
microtiter plate assay performed basically as described by Holo et al.
(15). Briefly, 96-well plates containing 50 µl of
twofold diluted fractions and 150 µl of the freshly diluted indicator
organism (2.5 × 106 CFU ml
1) per well
were incubated at 30°C for 16 h. Growth inhibition was
measured spectrophotometrically at 620 nm with a microtiter plate
reader (Dynatech MR5000; Dynatech Laboratories), and bacteriocin activity was calculated in bacteriocin units (BU). One BU was defined
as the reciprocal of the highest dilution of bacteriocin causing 50%
growth inhibition (50% of the turbidity of the control culture without bacteriocin).
Measurements of proton motive force.
The membrane
potential (
) of E. faecium T136 cells was
qualitatively measured with the fluorescent probe
3,3'-dipropylthiadicarbocyanine iodide
[(DiSC3(5)] (Molecular Probes Inc., Eugene,
Oreg.). Cells were harvested in the log phase (optical density at 660 nm [OD660], 0.6), washed twice with ice-cold 50 mM
potassium HEPES (K-HEPES) buffer, pH 7.0, resuspended in the same
buffer to 1/100 of their initial volume, and stored on ice.
Glucose-energized E. faecium T136 cells (final
OD660, 0.3) were added to a stirred cuvette containing 2 ml
of the K-HEPES buffer and DiSC3(5) (5 µM).
Next, nigericin (1.5 nM), which dissipates the pH gradient (
pH), and
enterocin P (200 BU/ml) or valinomicyn (1.5 nM) were added.
Fluorescence measurements were performed with a F1T11
spectrofluorometer (Spex Industries, Metuchen, N.J.) with a band-pass
width of 10 nm and wavelengths of 643 and 666 nm for excitation and
emission, respectively.
pH was measured by loading E. faecium
T136 cells (OD660, 0.6) with the fluorescent probe
2',7'-bis-(2-carboxyethyl)-5[and 6]-carboxyfluorescein acetoxymethyl
ester (BCECF AM) (Molecular Probes Inc.) by using an acid shock, as
described by Molenaar et al. (21). Glucose-energized,
BCECF-loaded cells (final OD660, 0.15) were added to a
stirred cuvette containing 2 ml of 50 mM KPi buffer, pH
6.0. Next, valinomycin (1.5 nM), which dissipates the 
, and
enterocin P (200 BU/ml) or nigericin (1.5 nM) were added. Fluorescence
was measured with band-pass widths of 5.0 and 15.0 nm and wavelengths
of 643 and 666 nm for excitation and emission, respectively.
Measurement of ATP.
E. faecium T136 cells grown
to an OD660 of 0.6 were collected by centrifugation, washed
once with 50 mM 2-(N-morpholino)ethanesulfonate (MES)
buffer, pH 6.5, and kept on ice until use. In order to energize the
cells prior to ATP measurements, they were resuspended to half of the
original volume in 50 mM MES buffer with 0.2% glucose and incubated
for 20 min. After treating the cells with 5, 20, 50, and 100 BU of
enterocin P/ml, total and external cellular ATP levels were determined
using the bioluminescence method described by Chen and Montville
(7) and an ATP bioluminescence assay kit (Sigma Chemical
Co., St. Louis, Mo.). Intracellular ATP was calculated by subtracting
external from total ATP. The assays were calibrated by using a standard
curve obtained by measuring the bioluminescence of ATP solutions of
known concentrations, and ATP levels were expressed as nmol
mg
1 of cells (dry weight). Values are the mean of
two independent bioluminiscence measurements.
Lipid extraction, preparation of CF-loaded liposomes, and CF
leakage assay.
E. faecium T136 cells were grown to
mid-log phase (OD660, 0.7 to 0.8), harvested, and washed
with 0.1% peptone water. Total E. faecium T136 lipids were
extracted following the procedure of Bligh and Dyer (as described
by New in reference 28) with the modifications introduced
by Winkowski et al. (35). Extracted lipids were kept at
20°C in glass vials and were used within 2 weeks. Next, large
unilamellar vesicles composed of lipids from E. faecium T136
and loaded with 6-carboxyfluorescein (CF) (Sigma Chemical Co.) were
prepared as described by Chen et al. (8). CF-loaded
liposomes were stored on ice and used within 3 h.
F0)/(F
F0), where Ft was the fluorescence at time t,
F0 was the control fluorescence at time t, and
F
was the fluorescence after the addition of Triton
X-100 (10% [vol/vol] in distilled H2O). The fluorescence values were corrected by subtracting the fluorescence of the control samples treated with 50 mM MES buffer instead of bacteriocins.
| |
RESULTS |
|---|
|
|
|---|
Effect of enterocin P on 
and
pH.
The effect of
enterocin P on the 
was qualitatively determined as quenching of
the fluorescent probe DiSC3(5) from the cells
treated with the bacteriocin (Fig. 1).
After glucose addition, an increase in the fluorescence occurred as a
result of the net proton extrusion by the membrane-bound
F0F1-ATPase. Upon addition of enterocin P to
energized, nigericin-treated cells, an increase in fluorescence
intensity was observed, which was an indication of a decrease in
internal membrane potential. After a short initial period, the
fluorescence increase induced by enterocin P was greater than that
provoked by valinomycin.
|

and resulted in a
fluorescence increase that was maintained until the addition of
nigericin, which rapidly reversed the pH to a level equal to that of
the medium pH. The addition of 200 BU of enterocin P ml
1
did not dissipate
pH. Furthermore, an increase in the pH gradient was observed upon bacteriocin treatment, which was more pronounced in
cells that had not been previously treated with valinomycin. Higher
enterocin P concentrations (i.e., 350 BU ml
1 [results
not shown]) produced similar behavior, i.e., a transient increase
preceding the fluorescence decrease.
|
Enterocin P depleted intracellular ATP levels of E. faecium T136 cells.
Upon energization, ATP levels of
E. faecium T136 cells increased to a mean value of 7.2 nmol
mg
1 of cells (dry weight). This value was similar to that
reported by Chen and Montville (7) for energized L. monocytogenes cells. Enterocin P depleted intracellular ATP in a
time- and concentration-dependent manner (Fig.
3). After 20 min of treatment, ATP levels
were 39, 14, and 0.2% of the original ATP concentrations for cells
that had been treated with 5, 20, and 50 BU ml
1,
respectively. Bacteriocin concentrations higher than 50 BU
ml
1 (i.e., 100 BU ml
1; data not shown) did
not induce any further intracellular ATP depletion. No significant
appearance of ATP was found in the external medium at any of the
enterocin P concentrations tested.
|
Enterocin P-induced CF efflux from E. faecium
T136-derived liposomes.
Exposure of E. faecium
T136-derived liposomes to enterocin P caused a gradual release of CF in
a concentration- and time-dependent fashion (Fig.
4). CF efflux plateaued earlier at the
lower enterocin P concentration (90 BU ml
1). After a
600-s treatment, the percentages of CF efflux were 19 and 33% for 90 and 450 BU ml
1 of enterocin P, respectively.
|
| |
DISCUSSION |
|---|
|
|
|---|
It is generally accepted that LAB bacteriocins act by
altering the permeability barrier of the cell membrane (13, 22, 33, 34, 35) and that one of the common mechanisms of inhibition of their target cells is the dissipation of the proton motive force
(PMF) (1, 5, 25). Since enterocin P is an amphipathic, cationic peptide (11), it may interact with the negatively
charged bacterial membranes of the sensitive cells and alter
their properties. In order to check this hypothesis, the components of
the PMF were measured in E. faecium T136 cells treated with
enterocin P. Enterocin P efficiently dissipated the 
of
nigericin-treated cells; the fact that the bacteriocin-induced 
dissipation was greater than the valinomycin-induced one may
indicate that mechanisms different from the simple outward diffusion of
the dye in response to the decrease in 
could be
involved, for example, several degrees of membrane disruption.
When the same concentration of enterocin P was used,
pH dissipation
of valinomycin-treated or untreated E. faecium T136 cells was not observed. Moreover, a slight increase in
pH was recorded, which was greater in cells not treated with valinomycin. This contrasts
with the observation that, generally, the
pH component of the PMF is
dissipated earlier than the 
one (5, 17, 32).
However, like enterocin P, lactococcin G, a monovalent cation-conducting bacteriocin (22, 23), and lacticin 3147 (20) exert a selective dissipation of 
and may cause
an increase in
pH. Moll et al. (23) explained this
effect by the enhanced H+ extrusion by the
F0F1-ATPase as a consequence of 
dissipation. In the case of lacticin 3147, a slow decrease in
pH was
observed after its increase. This may be a secondary effect of the
diminished intracellular ATP pool, which was depleted in an attempt to
maintain the PMF (20).
The energetic state of the cells treated with enterocin P was evaluated by measuring their ATP levels. The addition of enterocin P to energized E. faecium T136 cells induced intracellular ATP depletion without ATP efflux. This effect has been reported for several class II bacteriocins, such as lactacin F (1), pediocin PA-1 (7), lactococcin G (22), and mundticin (4). The ATP negative charge and size (Mw, 507) may play a role in determining its inability to pass through the pore. The fact that internal ATP may be depleted in the absence of ATP efflux suggests that it is hydrolyzed inside the sensitive cells. Two mechanisms have been proposed to explain the hydrolysis: (i) a shift in the equilibrium of the ATP hydrolysis reaction as a consequence of Pi loss through the membrane with impaired permeability (1) or (ii) accelerated hydrolysis due to the cell's attempt to regenerate the electrochemical gradient by H+ extrusion driven by the F0F1-ATPase energy-consuming pump (7, 23).
Finally, the effect of enterocin P in E. faecium T136-derived liposomes was determined. The bacteriocin induced CF efflux in liposomes in a time- and concentration-dependent fashion and in the absence of a PMF. CF release showed saturation kinetics and plateaued far from 100% efflux. This suggests that the permeabilization effect of enterocin P is transient in contrast with the "all or none" disruptive action of detergent peptides. The bacteriocin acts on liposomes in an energy-independent fashion.
The fact that enterocin P was able to act in a liposomal, protein-free system indicated that a receptor of a proteinaceous nature is not absolutely essential for bacteriocin action. The requirement of a receptor-like factor to exert antimicrobial activity has been suggested for the lactococcins A (33), B (34), and G (22) and some other class II bacteriocins. Although the broad antimicrobial spectrum of enterocin P (11) supports the evidence that a protein receptor is not a requirement for the activity, the activity enhancement in vivo by some proteinaceous components of the membrane or cell surface, or even the whole membrane constitution, should not be discarded (3, 9, 22).
Further studies will establish the ion specificity and the molecular mechanism of pore formation for enterocin P, including energy requirement and lipid dependence.
| |
ACKNOWLEDGMENTS |
|---|
Research in our laboratory and the preparation of the manuscript were supported by the U.S. Department of Agriculture CSREES NRI Food Safety Program (99-35201-8611), and other state and federal support was provided by the New Jersey Agricultural Experiment Station and by AGL2000-0707, Spain.
| |
FOOTNOTES |
|---|
* Corresponding author. Mailing address: Department of Food Science, Rutgers, The State University of New Jersey, 65 Dudley Rd., New Brunswick, NJ 08901-8520. Phone: (732) 932-9661, ext. 218. Fax: (732) 932-6776. E-mail: tchikindas{at}aesop.rutgers.edu.
| |
REFERENCES |
|---|
|
|
|---|
| 1. |
Abee, T.,
T. R. Klaenhammer, and L. Letellier.
1994.
Kinetic studies of the action of lactacin F, a bacteriocin produced by Lactobacillus johnsonii that forms poration complexes in the cytoplasmic membrane.
Appl. Environ. Microbiol.
60:1006-1013 |
| 2. |
Aymerich, T.,
H. Holo,
L. S. Ha![]() |
| 3. | Bennik, M. H. J., A. Verheul, T. Abee, G. Naaktgeboren-Stoffels, L. G. M. Gorris, and E. J. Smid. 1997. Interactions of nisin and pediocin PA-1 with closely related lactic acid bacteria that manifest over 100-fold differences in bacteriocin sensitivity. Appl. Environ. Microbiol. 63:3628-3636[Abstract]. |
| 4. | Bennik, M. H. J., B. Vanloo, R. Brasseur, L. G. M. Gorris, and E. J. Smid. 1998. A novel bacteriocin with a YGNGV motif from vegetable-associated Enterococcus mundtii: full characterization and interaction with target organisms. Biochim. Biophys. Acta 1373:47-58[Medline]. |
| 5. |
Bruno, M. E. C., and T. J. Montville.
1992.
Common mechanistic action of bacteriocins from lactic acid bacteria.
Appl. Environ. Microbiol.
59:3003-3010 |
| 6. | Casaus, P., T. Nilsen, L. M. Cintas, I. F. Nes, P. E. Hernández, and H. Holo. 1997. Enterocin B, a new bacteriocin from Enterococcus faecium T136 which can act synergistically with enterocin A. Microbiology 143:2287-2294[Abstract]. |
| 7. | Chen, Y., and T. J. Montville. 1995. Efflux of ions and ATP depletion induced by pediocin PA-1 are concomitant with cell death in Listeria monocytogenes Scott A. J. Appl. Bacteriol. 79:684-690. |
| 8. | Chen, Y., R. Shapira, M. Eisenstein, and T. J. Montville. 1997. Functional characterization of pediocin PA-1 binding to liposomes in the absence of a protein receptor and its relationship to a predicted tertiary structure. Appl. Environ. Microbiol. 63:524-531[Abstract]. |
| 9. | Chen, Y., R. D. Ludescher, and T. J. Montville. 1997. Electrostatic interactions, but not the YGNGV consensus motif, govern the binding of pediocin PA-1 and its fragments to phospholipid vesicles. Appl. Environ. Microbiol. 6:4770-4777. |
| 10. |
Chikindas, M. L.,
M. J. García-Garcera,
A. J. M. Driessen,
A. M. Ledeboer,
J. Nissen- Meyer,
I. F. Nes,
T. Abee,
W. N. Konings, and G. Venema.
1993.
Pediocin PA-1, a bacteriocin from Pediococcus acidilactici PAC 1.0, forms hydrophilic pores in the cytoplasmic membrane of target cells.
Appl. Environ. Microbiol.
59:3577-3584 |
| 11. | Cintas, L. M., P. Casaus, L. S. Håvarstein, P. E. Hernández, and I. F. Nes. 1997. Biochemical and genetic characterization of enterocin P, a novel sec-dependent bacteriocin from Enterococcus faecium P13 with a broad antimicrobial spectrum. Appl. Environ. Microbiol. 63:4321-4330[Abstract]. |
| 12. | Giraffa, G. 1995. Enterococcal bacteriocins: their potential as anti-listeria factors in dairy technology. Food Microbiol. 12:291-299. |
| 13. | González, B., E. Glaasker, E. R. S. Kunji, A. J. M. Driessen, J. E. Suárez, and W. N. Konings. 1996. Bactericidal mode of action of plantaricin C. Appl. Environ. Microbiol. 62:2701-2709[Abstract]. |
| 14. | Herranz, C., S. Mukhopadhyay, P. Casaus, J. M. Martínez, J. M. Rodríguez, I. F. Nes, L. M. Cintas, and P. E. Hernández. 1999. Biochemical and genetic evidence of enterocin P production by two Enterococcus faecium-like strains isolated from fermented sausages. Curr. Microbiol. 39:282-290[CrossRef][Medline]. |
| 15. |
Holo, H.,
O. Nilssen, and I. F. Nes.
1991.
Lactococcin A, a new bacteriocin from Lactococcus lactis subsp. cremoris: isolation and characterization of the protein and its gene.
J. Bacteriol.
173:3879-3887 |
| 16. |
Jack, R. W.,
J. R. Tagg, and B. Ray.
1995.
Bacteriocins of gram-positive bacteria.
Microbiol. Rev.
59:171-200 |
| 17. | Kaiser, A. L., and T. J. Montville. 1996. Purification of the bacteriocin bavaricin MN and characterization of its mode of action against Listeria monocytogenes Scott A cells and lipid vesicles. Appl. Environ. Microbiol. 62:4529-4535[Abstract]. |
| 18. | Klaenhammer, T. R. 1993. Genetics of bacteriocins produced by lactic acid bacteria. FEMS Microbiol. Rev. 12:39-86[Medline]. |
| 19. |
Lewus, C. B.,
A. Kaiser, and T. J. Montville.
1991.
Inhibition of food-borne bacterial pathogens by bacteriocins from lactic acid bacteria isolated from meat.
Appl. Environ. Microbiol.
57:1683-1688 |
| 20. |
McAuliffe, O.,
M. P. Ryan,
R. Paul Ross,
C. Hill,
P. Breeuwer, and T. Abbe.
1998.
Lacticin 3147, a broad-spectrum bacteriocin which selectively dissipates the membrane potential.
Appl. Environ. Microbiol.
64:439-444 |
| 21. | Molenaar, D., T. Abee, and W. N. Konings. 1991. Continuous measurement of the cytoplasmic pH in Lactococcus lactis with a fluorescent pH indicator. Biochim. Biophys. Acta 1115:75-83[Medline]. |
| 22. |
Moll, G.,
T. Ubbink-Kok,
H. Hildeng-Hauge,
J. Nissen-Meyer,
I. F. Nes,
W. N. Konings, and A. J. M. Driessen.
1996.
Lactococcin G is a potassium ion-conducting, two-component bacteriocin.
J. Bacteriol.
178:600-605 |
| 23. |
Moll, G.,
H. Hildeng-Hauge,
J. Nissen-Meyer,
I. F. Nes,
W. N. Konings, and A. J. M. Driessen.
1998.
Mechanistic properties of the two-component bacteriocin lactococcin G.
J. Bacteriol.
180:96-99 |
| 24. | Montville, T. J., and M. E. C. Bruno. 1994. Evidence that dissipation of proton motive force is a common mechanism of action for bacteriocins and other antimicrobial proteins. Int. J. Food Microbiol. 24:53-74[CrossRef][Medline]. |
| 25. | Montville, T. J., K. Winkowski, and R. D. Ludescher. 1995. Models and mechanism for bacteriocin action and applications. Int. Dairy J. 5:797-814[CrossRef]. |
| 26. | Montville, T. J., and Y. Chen. 1998. Mechanistic action of pediocin and nisin: recent progress and unresolved questions. Appl. Microbiol. Biotechnol. 50:511-519[CrossRef][Medline]. |
| 27. | Nes, I. F., D. Bao Diep, L. S. Havårstein, M. B. Brurberg, V. Eijsink, and H. Holo. 1996. Biosynthesis of bacteriocins in lactic acid bacteria. Antonie Van Leeuwenhoek 70:113-128[CrossRef][Medline]. |
| 28. | New, R. R. C. 1992. Liposomes: a practical approach, p. 253-266. IRL Press, Oxford, England. |
| 29. | Nissen-Meyer, J., and I. F. Nes. 1997. Ribosomally synthesized antimicrobial peptides: their function, structure, biogenesis, and mechanism of action. Arch. Microbiol. 167:67-77[CrossRef][Medline]. |
| 30. |
Pugsley, A. P.
1993.
The complete general secretory pathway in gram-negative bacteria.
Microbiol. Rev.
57:50-108 |
| 31. | Stiles, M. E. 1996. Biopreservation by lactic acid bacteria. Antonie van Leeuwenhoek 70:331-345[CrossRef][Medline]. |
| 32. | Tahara, T., M. Oshimura, C. Umezawa, and K. Kanatani. 1996. Isolation, partial characterization, and mode of action of acidocin J1132, a two-component bacteriocin produced by Lactobacillus acidophilus JCM 1132. Appl. Environ. Microbiol. 62:892-897[Abstract]. |
| 33. |
Van Belkum, M. J.,
J. Kok,
G. Venema,
H. Holo,
I. F. Nes,
W. N. Konings, and T. Abee.
1991.
The bacteriocin lactococcin A specifically increases permeability of lactococcal cytoplasmic membranes in a voltage-independent, protein-mediated manner.
J. Bacteriol.
173:7934-7941 |
| 34. |
Venema, K.,
T. Abee,
A. J. Haandrikman,
K. J. Leenhouts,
J. Kok,
W. N. Konings, and G. Venema.
1993.
Mode of action of lactococcin B, a thiol-activated bacteriocin from Lactococcus lactis.
Appl. Environ. Microbiol.
59:1041-1048 |
| 35. | Winkowski, K., R. Ludescher, and T. J. Montville. 1996. Physicochemical characterization of the nisin-membrane interaction with liposomes derived from Listeria monocytogenes. Appl. Environ. Microbiol. 62:323-327[Abstract]. |
This article has been cited by other articles:
| |||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
| J. Bacteriol. | Microbiol. Mol. Biol. Rev. | Eukaryot. Cell | All ASM Journals |
|---|